Financials

  • Market Capitalization 46.69 M
  • Employee 18
  • Founded 2020
  • CEO N/A
  • Website www.tevogen.com
  • Headquarter Delaware, United States
  • FIGI BBG013395405
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-0.91
ratio cours/chiffre d'affaires
-67.95

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
4260
HYPD
Hyperion DeFi, Inc. - Common Stock
3.09 USD-9.65%-7.49%+17.49%-47.89%48.02 M USD
4267
ATYR
aTyr Pharma, Inc. - Common Stock
0.48 USD-9.43%-15.79%-2.04%-50.52%47.08 M USD
4274
HOWL
Werewolf Therapeutics, Inc. - Common Stock
0.96 USD+2.13%+6.67%+166.67%-26.15%46.66 M USD
4279
EDSA
Edesa Biotech, Inc. - Common Shares
4.78 USD+0.84%+6.22%-6.09%+103.40%46.08 M USD

Nouvelles